THE OXFORD OPHTHALMOLOGICAL CONGRESS
Advancing education in the science and practical development of ophthalmology and allied subjects, principally through an annual scientific congress. Promoting scientific research relating to ophthalmology and allied subjects by providing a platform for presentation and dissemination of such research and by the provision of grants and bursaries in support of such research.
Financial health, per its FY2024 accounts
The charity reported a net surplus of £35,852 for the year ended 31 December 2024, driven by increased income from its Congress and investment gains. It holds unrestricted reserves of £353,181, which the trustees consider sufficient to cover future commitments and potential reductions in incoming resources. The financial position is described as healthy and solvent with no material uncertainties.
What the accounts disclose
“Attendance, accommodation and annual dinner 202,196” — page 15
“We aim to hold reserves almost equal to that of the anticipated total cost of holding future Congresses and associated expenditure ensuring that we could continue to meet our financial commitments and contractual obligations in the unlikely eventuality that we received no funding from our members/attendees for at least one entire financial year.” — page 6
Funders the charity credits
- Roche Products Ltd
Register events
- Received assets from another charity (09/03/2020)
Trustees
- CHRISTOPHER WILLIAM KINDER
- Dr Marie Ursula Hickey-Dwyer
- Manoj Parulekar
- Prof Mandeep Singh Sagoo
- Prof Susan Mollan
- Samantha de Silva
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £202k | £190k |
| 31/12/2023 | £112k | £129k |
| 31/12/2022 | £128k | £114k |
| 31/12/2021 | £32k | £33k |
| 31/12/2020 | £70 | £33k |
Common questions
Is THE OXFORD OPHTHALMOLOGICAL CONGRESS financially healthy?
Per its FY2024 accounts: The charity reported a net surplus of £35,852 for the year ended 31 December 2024, driven by increased income from its Congress and investment gains. It holds unrestricted reserves of £353,181, which the trustees consider sufficient to cover future commitments and potential reductions in incoming resources. The financial position is described as healthy and solvent with no material uncertainties. Its FY2024 accounts were independently examined.